ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini+13 more
wiley +1 more source
SNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights
ABSTRACT Objective SNUPN‐related muscular dystrophy or LGMDR29 is a new entity that covers from a congenital or childhood onset pure muscular dystrophy to more complex phenotypes combining neurodevelopmental features, cataracts, or spinocerebellar ataxia. So far, 12 different variants have been described.
Nuria Muelas+18 more
wiley +1 more source
Cause of death statistics in 2022 in the Republic of Korea. [PDF]
Oh JH, Seo J, Park HJ.
europepmc +1 more source
Identify Sensitive Periods for Onset and Resolution of Hypertension and Its Subtypes Over the Lifespan. [PDF]
Meng X+8 more
europepmc +1 more source
Epidemiology of Hypertension in Bangladeshi People with Type 2 Diabetes Attending an Urban Healthcare Center: Impact of the 2017 American College of Cardiology (ACC)/American Heart Association (AHA) Hypertension Clinical Practice Guidelines. [PDF]
Rakibul-Hasan M, Yeasna KF, Mohana CA.
europepmc +1 more source
Comparing Parkinson's Disease Medications Categorised by Location in New South Wales, Australia: Linking the 45 and Up Study and the Pharmaceutical Benefits Scheme (PBS) Data. [PDF]
Logan PA+4 more
europepmc +1 more source
Health and economic burden of herpes zoster in adults in Finland: A retrospective nationwide database study. [PDF]
Kanerva M+6 more
europepmc +1 more source
Emergency Surgery for Acute Left-Sided Complicated Diverticulitis in the Elderly: What Are the Predictor Factors of Mortality and Morbidity? [PDF]
Vaccari S+7 more
europepmc +1 more source